Miranda Schmalfuhs

Biotech in the Empire State: Building a World-Class Bioscience Ecosystem in New York

Jennifer Hawks Bland, CEO of NewYorkBIO, shares her inspiring journey from a legal career to leading New York’s burgeoning bioscience ecosystem. Throughout her interview with 

, Jennifer discusses the unique strengths of New York as a biotech hub, including its world-renowned academic institutions, diverse population for clinical research, and robust financial infrastructure. She highlights NewYorkBIO’s role in fostering innovation, supporting early-stage companies, and connecting industry leaders. With her vision to position New York as a global leader in bioscience, Jennifer offers insights into the collaborative efforts shaping the future of biotechnology in the Empire State.

Student Pharmacists Can Help End the HIV/AIDS Epidemic

As future health care professionals, pharmacy students need to understand various elements of HIV to expand access to care and effective treatment. Students should have an understanding of what HIV/AIDS is, available testing options, HIV pharmacotherapy, pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP) to help aid in the fight against the epidemic.

US Treasury Is Latest Victim of Most ‘Persistent’ Hacking Threat

A growing roster of political figures, US government agencies and companies that provide critical services have one thing in common: They have allegedly been hacked by China.

The latest victim is the US Treasury Department, which disclosed that Chinese state-sponsored hackers had breached its network via a third-party provider, accessing some unclassified documents.

The "Microscopy: Global Market" report has been added to ResearchAndMarkets.com's offering.

The Global Microscopy Market was valued at USD 9.7 Billion in 2024, and is expected to reach USD 13.3 Billion by 2029, rising at a CAGR of 6.60%.

The scope of this study encompasses an analysis of the global microscopy market. The Research evaluates it based on product type, which includes microscope types and accessories and supplies. The market is also analyzed based on application. The Research determines the current market status in each segment, examines its impact on future needs and presents growth forecasts over the next five years.

Innovative partnerships and technological advancements are essential to transforming healthcare supply chains into more agile, sustainable, and patient-centric systems that not only enhance efficiency but also significantly improve health outcomes.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 

Articles

The latest news for pharma industry insiders.

Pharma Pulse 1/6/25: Building a World-Class Bioscience Ecosystem, Student Pharmacists Can Help End the HIV/AIDS Epidemic & more

Navigating Fertility Misinformation on Social Media

In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (

), discusses the biggest misconceptions about fertility that he sees circulating on social media and work he does to correct and prevent them.

Study Finds Nearly 75% of Adolescents Experience Depression, Anxiety

Female adolescents were at an increased risk of experiencing depression and anxiety symptoms compared with males.

A.I., the Electricians and the Boom Towns of Central Washington

The rural region is changing fast as electricians from around the country plug the tech industry’s new, giant data centers into its ample power supply.

McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses

McKesson Corporation reported that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm. This transaction enables the Company to focus capital deployment and prioritize investments expanding its strategic oncology and biopharma growth platforms.

🌟 Exciting End-of-Year Highlights from Systech International!

As we wrap up 2024, we’re reflecting on key developments like the phased approach to DSCSA compliance and its impact on the pharmaceutical supply chain. Our Director of Product Management, Joseph Lipari, shared valuable insights in a two-part interview with 

, covering the latest updates, deadlines, and strategies for compliance.

This year also saw us offering tips to streamline traceability and exception management, ensuring smoother transitions for industry stakeholders.

Read the full article and stay tuned for more insights into trends and innovations shaping 2025! 🚀

#DSCSA #pharma #traceability

Pharma Pulse 1/3/25: Navigating Fertility Misinformation on Social Media, Nearly 75% of Adolescents Experience Depression/Anxiety & more

Check out our top five most engaged social media posts from the year 2024.

Our Top 5 Social Media Posts of 2024

Implementing Sustainable Business Practices

Raphael Chin Fo Sieeuw, DHL’s VP of life sciences and healthcare, Americas, uncovers:

How his plethora of experience successfully prepared him to perform the required duties in his current position

The latest trends that are helping to reshape and impact the pharma supply chain

What can be done to combat 300 million tons of plastic waste every year that the global healthcare sector generates (according to the World Health Organization)

How the industry can continue to dig itself out of the national drug shortage hole

Chip Davis, president and CEO of the Healthcare Distribution Alliance (HDA), a national organization that represents primary pharmaceutical distributors, discusses:

The benefits of the Distribution Management Conference, and the value it provides for the industry

A three-year check-in since his last chat with Pharmaceutical Commerce, including a look at how the challenges presented to distributors now differ, and how they are being addressed

Progress that has been made toward full connectivity since the FDA announced a “stabilization period” to finalize implementation of the DSCSA before November 2024, along with some of the most significant issues for trading partners

Some of the root causes of drug shortages, and how distributors are work to mitigate them

Key initiatives and plans that the HDA is focused on for the second half of 2024, and how these will shape the future of the pharmaceutical supply chain

Chris Williams, International Managing Director of Alloga Europe and ICS, discusses:

What’s needed to support advanced therapy medicinal products from a temperature standpoint

The current state of third-party logistics (3PLs) in Europe and what areas need to improve

How expectations of pharma companies have changed in terms of what they expect a 3PL partner to provide

How Alloga’s new facilities in Spain and the Netherlands fit within the company’s strategy

What he believes 3PLs can do to support supply chains more efficiently

Allen Jacques, a life sciences industry thought leader at Kinaxis, dives into:

What he sees as limitations of current government efforts when it comes to boosting domestic production of essential medicines, and why they aren’t sufficient

The challenges that generic drug manufacturers are facing today

Why more resilient and transparent supply chains are necessary in the pharmaceutical industry, and how these can help mitigate shortage issues

The Impact of RFID: Enhancing Medication Management

Rob Sobie, chief product officer of Intelliguard, a provider of hospital medication management and data intelligence solutions, discusses:

The key challenges that hospitals are currently facing

Why he believes that the drug supply chain is failing

Successes surrounding the implementation of RFID technology

A high-level overview of the Drug Supply Chain Security Act, along with his thoughts on the latest exemptions that were recently announced by the FDA

The top five episodes of our podcast in the year 2024, highlighted. 